Target intelligence / Profile preview

Urea cycle enzyme

Molecular classification
Enzyme
01

Overview

The urea cycle consists of a series of five main enzymes — carbamoyl phosphate synthetase 1 (CPS1), ornithine transcarbamylase (OTC), argininosuccinate synthetase (ASS1), argininosuccinate lyase (ASL), and arginase 1 (ARG1) — working together primarily in the liver to convert highly toxic ammonia, a byproduct of amino acid catabolism, into the much less toxic urea for safe excretion by the kidneys. Additional supporting enzymes and transporters, such as N-acetylglutamate synthase (NAGS) and ornithine/citrulline antiporters, are involved in the cycle’s proper function. Genetic or acquired defects in these enzymes result in urea cycle disorders characterized by hyperammonemia, leading to serious neurological and systemic complications. Several drugs target this pathway by either activating defective enzymes or providing alternative routes for waste nitrogen excretion

Other names
Urea cycle enzymeCarbamoyl phosphate synthetase 1 (CPS1)Ornithine transcarbamylase (OTC)Argininosuccinate synthetase (ASS1)Argininosuccinate lyase (ASL)Arginase 1 (ARG1)
02

Mechanism of action

Ammonia scavenging (drugs convert ammonia into excretable conjugates) Activation of N-acetylglutamate synthase (by carglumic acid)

03

Biological functions

Ammonia detoxificationNitrogen metabolismAmino acid catabolismUrea biosynthesis
04

Disease associations

Urea cycle disorderHyperammonemiaNeurological dysfunction due to ammonia toxicity
05

Safety considerations

Risk of hyperammonemia if enzyme function is insufficientRisk of neurological toxicity due to ammonia accumulationDrug toxicity (e.g. sodium overload, metabolic acidosis)
06

Interacting drugs

Sodium phenylbutyrate

3 more in the full profile.

07

Biomarkers

Plasma ammoniaPlasma glutaminePlasma argininePlasma citrullinePlasma orotic acid

Beyond the preview

Go deeper on Urea cycle enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urea cycle enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call